Oxandrolone 10mg/tab 100 Tabletten by Rossiaz Lab

Usage

1. Establish your PCT start date by calculating clearance time for the longest-ester compound in your completed cycle — begin Oxandrolone the day the primary compound is confirmed pharmacologically absent.
2. Set your opening Oxandrolone dose based on the intensity and duration of the preceding cycle: 20mg per day for cycles lasting 10+ weeks with suppressive compounds; 10mg per day for shorter or less suppressive cycles.
3. Introduce your chosen SERM (tamoxifen or clomiphene) on the same first day as Oxandrolone — the two operate through different mechanisms and are not interchangeable; concurrent use is the standard PCT framework.
4. Split the daily Oxandrolone dose into two administrations (morning and early afternoon) to maintain consistent plasma exposure across the day without a late-evening dose that may interfere with nocturnal hormonal rhythms.
5. At week four of PCT, complete a bloodwork panel covering LH, FSH, total testosterone, and liver enzymes — use the results to determine whether you step down to 10mg/day, hold at current dose, or prepare for exit.
6. Execute the final taper by reducing to 10mg per day for one to two weeks before discontinuing entirely; do not stop abruptly from 20mg as this creates a secondary withdrawal signal during an already sensitive hormonal recovery period.

Warnings

Frequently asked questions

When is the right time to introduce Oxandrolone into a post-cycle therapy plan?

Oxandrolone should be introduced at the start of the PCT phase — the day after the primary cycle's last active compound clears — rather than during the cycle itself. For long-ester testosterone cycles, this means waiting 14–18 days post-final-injection before beginning Oxandrolone alongside SERM therapy. Starting at this point ensures Oxandrolone's nitrogen-retention effect bridges the gap between declining exogenous androgens and rising endogenous testosterone.

Which PCT drugs are typically run alongside Oxandrolone during hormonal recovery?

Tamoxifen (Nolvadex) and clomiphene citrate (Clomid) are the two most widely documented SERM agents run alongside Oxandrolone in PCT protocols. Tamoxifen at 20–40mg per day drives LH and FSH recovery while Oxandrolone maintains androgen-receptor stimulus to slow catabolic rebound. Some practitioners add HCG in the pre-PCT bridge period to prime testicular responsiveness before SERM therapy begins.

How long should an Oxandrolone-supported PCT phase last before complete discontinuation?

A structured Oxandrolone-supported PCT typically runs four to six weeks, with the Oxandrolone component stepped down during the final two weeks rather than stopped abruptly. Recovery bloodwork — specifically LH, FSH, and total testosterone at week four — guides whether the taper extends to six weeks or concludes at four. Full HPG-axis normalisation, confirmed by testosterone returning to pre-cycle baseline, is the endpoint, not a fixed calendar date.

Why does the 10mg tablet format give a specific advantage during PCT compared to 25mg or 50mg formats?

PCT dosing requires genuine downward flexibility — reducing exposure by exactly 10mg per step as recovery progresses. A 25mg or 50mg tablet cannot be accurately split into consistent sub-doses, meaning dose reductions in those formats involve either tablet-splitting error or large irregular jumps. Rossiaz Lab's 10mg unit allows a clean one-tablet step-down from 20mg to 10mg to zero without any tablet division.

How does the 100-tablet pack size map to a complete PCT protocol at standard recovery doses?

At 20mg per day (two tablets) for the first three weeks of PCT and 10mg per day (one tablet) for the final two weeks, a five-week structured PCT requires 490mg of total Oxandrolone — covered entirely by one 100-tablet pack at 10mg per tab with tablets remaining. The same pack also accommodates a conservative 10mg-per-day ten-week PCT taper, making it the only pack size that covers both short and extended recovery timelines without requiring a second order. (2) angle_used

Manufacturer

Rossiaz Lab's international distribution architecture is built around a central principle: regional availability must not compromise the documentation chain that connects each tablet batch to its analytical release data. For Oxandrolone 10mg/tab, this means the same lot-traceable Certificate of Analysis — covering reversed-phase HPLC potency quantification and LAL endotoxin clearance — accompanies the product whether it is shipped to a verified reseller in Western Europe, dispatched to a customer in the UK, or fulfilled through a North American distribution partner. Rather than maintaining separate quality tiers by region, Rossiaz Lab applies a single release standard across all markets: no batch ships without a closed lot number linked to confirmed analytical data accessible to the end user on request. This distribution-neutral quality commitment is the operational basis on which the brand has expanded its international footprint without accepting region-specific compromises in documentation rigour.